PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy
Soheila Fattahi, Zahra Khalifehzadeh-Esfahani, Mina Mohammad-Rezaei, Sahar Mafi, Morteza Jafarinia
Topics & Concepts
PI3K/AKT/mTOR pathwayProtein kinase BmTORC1Mechanistic target of rapamycinCoronavirusMedicineImmunologyBiologyVirologySignal transductionDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Internal medicineBiochemistryPI3K/AKT/mTOR signaling in cancerSARS-CoV-2 and COVID-19 ResearchCRISPR and Genetic Engineering